Financhill
Back

Elite Pharmaceuticals 10K Form

Sell
50

ELTP
Elite Pharmaceuticals

Last Price:
0.52
Seasonality Move:
11.78%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive ELTP News And Ratings

See the #1 stock for the next 7 days that we like better than ELTP

ELTP Financial Statistics

Sales & Book Value

Annual Sales: $56.63M
Cash Flow: $1.47M
Price / Cash Flow: 6263.02
Annual Sales: $0.05
Price / Book: 9.35

Profitability

EPS (TTM): 0.01130
Net Income (TTM): $19.58M
Gross Margin: $26.36M
Return on Equity: 41.23%
Return on Assets: 26.94%

Elite Pharmaceuticals Earnings Forecast

Key Elite Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 18 years for ELTP is 46.55%.
  • The Selling, General & Administrative Expenses for ELTP have been equal to 12.90% of Gross Profit Margin.
  • The Research & Development expenses have been 12.16% of Revenue.
  • The Interest Expense is 2.93% of Operating Income.
  • The Net Earning history of ELTP is 35.51% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 12 years.

Elite Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ELTP
Website: elitepharma.com

Debt

Debt-to-Equity Ratio: 0.13
Current Ratio: 3.08
Quick Ratio: 2.06

Price-to-Earnings

Trailing P/E Ratio: 25.49
Forward P/E Ratio: 0

ELTP Technical Analysis vs Fundamental Analysis

Sell
50
Elite Pharmaceuticals (ELTP) is a Sell

Is Elite Pharmaceuticals a Buy or a Sell?